Subscribe: Medscape Medical Students Headlines
http://www.medscape.com/cx/rssfeeds/2681.xml
Preview: Medscape Medical Students Headlines

Medscape Medical Students Headlines



Latest medical news, articles, and features from Medscape Med Students



 



A 19-Year-Old Woman With Abdominal Pain and DiarrheaA 19-Year-Old Woman With Abdominal Pain and Diarrhea

Fri, 22 Sep 2017 12:00:00 EDT

A 19-year-old woman presents due to fevers, nausea, severe abdominal pain, and watery diarrhea. The symptoms have been on-and-off over the past few months. What treatment is indicated?
Osmosis



Tuberculosis: Osmosis Study Video Tuberculosis: Osmosis Study Video

Fri, 22 Sep 2017 12:00:00 EDT

This video covers the pathophysiology of tuberculosis infection, as well as important complications, signs and symptoms, tests and procedures, and treatment.
Osmosis



Misdosing Ocaliva for Liver Disorder Can Be Fatal, FDA SaysMisdosing Ocaliva for Liver Disorder Can Be Fatal, FDA Says

Thu, 21 Sep 2017 16:57:30 EDT

Some patients with primary biliary cholangitis have developed serious liver injury or have died after receiving higher doses of obeticholic acid than the FDA recommends in the product label.
News Alerts



How Residents Cope: Binging, Drinking, Sports, and FriendsHow Residents Cope: Binging, Drinking, Sports, and Friends

Wed, 20 Sep 2017 12:00:00 EDT

Overeating. Drinking. Antidepressants. These are a few of the coping mechanisms residents rely on to get through their stressful residencies. Are there any positive coping strategies?
Medscape Business of Medicine



FDA Approves Trelegy Ellipta for COPDFDA Approves Trelegy Ellipta for COPD

Tue, 19 Sep 2017 13:57:51 EDT

The FDA has approved once-daily, single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta, GlaxoSmithKline) for patients with COPD.
FDA Approvals



FDA Clears Liquid Extended-Release Amphetamine for ADHDFDA Clears Liquid Extended-Release Amphetamine for ADHD

Tue, 19 Sep 2017 13:34:23 EDT

Adzenys ER, a liquid extended-release amphetamine product, is another treatment option for patients aged 6 years and older with attention-deficit/hyperactivity disorder (ADHD).
FDA Approvals



EU Regulators Approve Self-injectable Belimumab for Lupus EU Regulators Approve Self-injectable Belimumab for Lupus

Fri, 15 Sep 2017 18:52:19 EDT

The new version of belimumab can spare patients with systemic lupus erythematosus the need to have an intravenous infusion of the drug at a hospital or clinic.
International Approvals



FDA Clears First Generic Tamiflu for Oral SuspensionFDA Clears First Generic Tamiflu for Oral Suspension

Fri, 15 Sep 2017 17:04:20 EDT

Oseltamivir phosphate (Tamiflu) for oral suspension 6 mg(base)/mL, made by Nesher Pharmaceuticals LLC, is particularly important for patients who can't swallow pills, the FDA notes.
FDA Approvals



EMA Panel Backs Two New Inhalers for COPDEMA Panel Backs Two New Inhalers for COPD

Fri, 15 Sep 2017 15:02:26 EDT

Elebrato Ellipta and Trelegy Ellipta contain the triple combination of fluticasone furoate, umeclidinium, and vilanterol and are for inadequately controlled moderate to severe COPD in adults.
International Approvals



Guselkumab (Tremfya) Gets CHMP Backing for Plaque PsoriasisGuselkumab (Tremfya) Gets CHMP Backing for Plaque Psoriasis

Fri, 15 Sep 2017 14:13:44 EDT

The drug selectively targets IL-23, a key driver of the immune inflammatory response in patients with psoriasis.
International Approvals



A 55-Year-Old Woman With Shortness of Breath and Chest PainA 55-Year-Old Woman With Shortness of Breath and Chest Pain

Fri, 15 Sep 2017 12:00:00 EDT

A 55-year-old woman is admitted due to shortness of breath and pain on both sides of her chest with deep breathing, which has worsened over the past 5 days. Can you make the diagnosis?
Osmosis